¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"contrast agent nephrotoxicity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® nephrotoxicity ÇÑ±Û ÄáÆÏµ¶¼º, ½Åµ¶¼º
¼³¸í   
  ÄáÆÏÀÇ ´¢¼¼°ü ¼¼Æ÷¿¡ µ¶¼ºÀÌ ÀÖ´Â, ¶Ç´Â ÆÄ±«Çϴ ¼ºÁú.
¿µ¹® contrast ÇÑ±Û ´ëÁ¶
¼³¸í   
  Â÷À̸¦ ¸íÈ®È÷ Çϱâ À§ÇÑ ºñ±³, ´ëºñ. ´ë»ó¹°ÀÇ ±¸¼º ¿ä¼Ò¿¡ ÀÇÇÏ¿© »ý±ä »çÁø ¶Ç´Â Çʸ§ÀÇ ³óµµ º¯È­¿¡ °üÇÑ ½Äº°¿ª.
¿µ¹® contrast media ÇÑ±Û Á¶¿µÁ¦
¼³¸í   
  ¹æ»ç¼± ÃÔ¿µ½Ã¿¡ Èñ°Ô ³ª¿À´Â ¹°Áú·Î ´Ü¼ø ¹æ»ç¼± ÃÔ¿µÀ¸·Î º¸ÀÌÁö ¾Ê´Â ºÎÀ§¸¦ º¸±âÀ§Çؼ­ ±× ºÎºÐ¿¡ ¹°ÁúÀ» ³Ö¾î¼­ ±× ºÎºÐÀÇ ¸ð¾çÀ» ³ªÅ¸³»°Ô Çϴ ¹°Áú.
¿µ¹® cardiotonic, cardiotonic agent ÇÑ±Û °­½ÉÁ¦
¼³¸í   
  ½ÉÀåÀÇ ¼öÃà·ÂÀ» Áõ°¨½Ã۴ ¾à¹°À» ¸»ÇÑ´Ù. ±âº»ÀûÀ¸·Î ½É±Ù¼öÃà·ÂÀ» Áõ°­½ÃÄÑ ½ÉÀå¹ÚÃâ·®À» Áõ°¡½Ã۴ ¾à¹°ÀÌ´Ù. °­½É¹è´çü, Æ÷½ºÆ÷µð¿¡½ºÆ®¶ó¾ÆÁ¦ ¾ïÁ¦Á¦, ¾Æµå·¹³¯¸° ¥â¼ö¿ëüÀÛ¿ëÁ¦, Ç÷°üÈ®ÀåÁ¦ µîÀÌ ÀÖ´Ù. ´ëÇ¥ÀûÀΠ¿¹·Î¼­´Â µð°î½Å(digoxine) µîÀÇ µðÁöÅ»¸®½º(digitalis)°¡ ÀÖ´Ù.
¿µ¹® alkylating agent ÇÑ±Û ¾Ëųȭ¾à¹°
¼³¸í   
  Ç×¾ÏÁ¦ÀÇ ÀÏÁ¾. ÀÌ»óÀûÀΠÇ×¾ÏÁ¦´Â Á¤»óÀûÀΠ¼¼Æ÷¿¡´Â Çظ¦ ÁÖÁö ¾Ê°í ´ÜÁö ¾Ï¼¼Æ÷¿¡¸¸ Ä¡¸íÀûÀΠȿ°ú¸¦ ³ªÅ¸³»¾ß ÇÑ´Ù. ÀÌ·¸°Ô ÇÏ·Á¸é ¾Ï¼¼Æ÷¸¸ÀǠƯÀÌÇѠƯ¼ºÀ» ÀÌÇØÇÏ°í ±×°÷¿¡¸¸ ÀÛ¿ëÇϴ ¾à¹°À» °³¹ßÇØ¾ß ÇÑ´Ù. ÇöÀç ´ëºÎºÐÀÇ Ç×¾ÏÁ¦´Â ¾Ï¼¼Æ÷°¡ Á¤»ó ¼¼Æ÷¿¡ ºñÇÏ¿© ¿ùµîÈ÷ Áõ½ÄÀ» »¡¸®ÇѴٴ Ư¼ºÀ» ÀÌ¿ëÇϰí ÀÖ´Ù. Áõ½ÄÀÌ ºü¸£´Ù´Â °ÍÀº ´Ù½Ã ¸»Çϸé À¯Àü Á¤º¸¸¦ °¡Áö°í Àִ DNAÀÇ º¹Á¦°¡ ºü¸£´Ù´Â °ÍÀ» ÀǹÌÇÑ´Ù. ¸¸¾à DNAÀÇ º¹Á¦¸¦ ¹æÇØÇÑ´Ù¸é Áõ½ÄÀÌ ¾ÆÁÖ ºü¸¥ ¾Ï¼¼Æ÷¿¡°Ô´Â Ä¡¸íÀûÀÌÁö¸¸ ¿µ¿øÈ÷ Áõ½ÄÀ» ÇÏÁö ¾Ê´Â DNAÀÇ º¹Á¦°¡ °ÅÀÇ ÇÊ¿ä¾ø´Â)½Å°æ¼¼Æ÷³ª Áõ½ÄÀÌ ¾Ï¼¼Æ÷¿¡ ºñÇØ¼­ ¾ÆÁÖ ´À¸° Á¤»ó¼¼Æ÷¿¡´Â °ÅÀÇ ¿µÇâÀ» ÁÖÁö ¸øÇÑ´Ù. ÇÏÁö¸¸ ½Åü¿¡¼­µµ Áõ½ÄÀÌ ¾Ï¼¼Æ÷¿Í ºñ½ÁÇÑ ¼öÁØÀ¸·Î ÀϾ´Â Á¤»óÀûÀΠ¼¼Æ÷°¡ Àִµ¥ ±×°ÍÀº ¸Ó¸®Ä«¶ôÀ» ¸¸µå´Â ¸ð³¶¼¼Æ÷¿Í ¼ÒÈ­°üÀÇ Á¡¸·À» ÀÌ·ç´Â ¼¼Æ÷¿Í Ç÷¾×ÀÇ ¼¼Æ÷¸¦ ¸¸µå´Â °ñ¼ö ¼¼Æ÷ÀÌ´Ù. ±×·¯¹Ç·Î Ç×¾ÏÁ¦¸¦ »ç¿ëÇÒ °æ¿ì ¾Ï¼¼Æ÷¿Í ¸¶Âù°¡Áö·Î À̵頼¼Æ÷µµ ÇÔ²² Ä¡¸íÀûÀΠ¿µÇâÀ» ÀÔÀ» °ÍÀº ´ç¿¬ÇÏ´Ù(±×·¡¼­ Ç×¾ÏÁ¦ Ä¡·á½Ã¿£ ¸Ó¸®°¡ ºüÁö°í ¼ÒÈ­ºÒ·®ÀÌ Àß ¿Â´Ù). ¾ËĮȭ¾à¹°ÀÇ °æ¿ì¿¡´Â DNA¿Í Á÷Á¢ °áÇÕÀ» ÇÏ¿© DNAÀÇ º¹Á¦¸¦ ¾ïÁ¦ÇÔÀ¸·Î½á Ç×¾ÏÁ¦ÀÇ ¿ªÇÒÀ» ¼öÇàÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephrotoxicity
    ÄáÆÏµ¶¼º, ½Åµ¶¼º
  • contrast agent
    Á¶¿µÁ¦
  • binocular contrast
    ¾ç¾È´ëºñ, µÎ´«´ëºñ
  • barium contrast medium
    ¹Ù·ýÁ¶¿µÁ¦
  • color contrast
    »ö´ëºñ, »ö´ëÁ¶
  • contrast
    1. ´ëÁ¶, ´ëºñ 2. ´ëÁ¶µµ
  • contrast bath
    ¿Â³Ã±³´ë¸ñ¿å
  • contrast echocardiography
    Á¶¿µ½É(Àå)ÃÊÀ½ÆÄ°Ë»ç, Á¶¿µ½É(Àå)ÃÊÀ½ÆÄ(¼ú)
  • contrast enema
    1. Á¶¿µ°üÀå 2. Á¶¿µ°üÀå¾×
  • contrast enhancement
    Á¶¿µÁõ°­
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast enhancement scan
    Á¶¿µÁõ°­½ºÄµ
  • contrast material
    Á¶¿µÀç
  • contrast media
    Á¶¿µÁ¦
  • contrast medium
    Á¶¿µÁ¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephrotoxicity
    ÄáÆÏµ¶¼º, ½Åµ¶¼º
  • contrast
    ´ëÁ¶
  • phase contrast
    À§»ó´ëÁ¶
  • contrast medium
    Á¶¿µÁ¦
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • contrast ventriculography
    Á¶¿µ³ú½ÇÁ¶¿µ¼ú, Á¶¿µ½É½ÇÁ¶¿µ¼ú
  • agent
    1. ¾à¹°, ¾àÁ¦, 2. ¹°Áú, 3. ÀÎÀÚ
  • alkylating agent
    ¾Ëųȭ¾à¹°, ¾ËųȭÁ¦
  • anti-inflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • antiasthmatic agent
    Ç×õ½ÄÁ¦
  • antifungal agent
    Ç×Áø±ÕÁ¦
  • antimetabolic agent
    Ç×´ë»ç¹°Áú
  • antitumor agent
    Ç×¾ÏÁ¦
  • blocking agent
    Â÷´ÜÁ¦
  • etiologic agent
    ¿øÀÎü, º´ÀÎü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephrotoxicity
    ÄáÆÏµ¶¼º, ½Åµ¶¼º
  • contrast agent
    Á¶¿µÁ¦
  • 3D phase contrast angiography
    »ïÂ÷¿øÀ§»ó´ëÁ¶Ç÷°üÁ¶¿µ¼ú
  • barium contrast medium
    ¹Ù·ýÁ¶¿µÁ¦
  • binocular contrast
    ¾ç¾È´ëºñ, µÎ´«´ëºñ
  • blood oxygenation level dependant contrast
    Ç÷Áß»ê¼ÒÄ¡ÀÇÁ¸´ëÁ¶µµ
  • contrast bath
    ¿Â³Ã±³´ë¸ñ¿å
  • contrast
    ´ëÁ¶
  • color contrast
    »ö´ëºñ, »ö´ëÁ¶
  • contrast echocardiography
    Á¶¿µ½ÉÀåÃÊÀ½ÆÄ°Ë»ç, Á¶¿µ½ÉÃÊÀ½ÆÄ°Ë»ç
  • contrast enema
    Á¶¿µ°üÀå
  • contrast enhancement
    Á¶¿µÁõ°­
  • contrast material
    Á¶¿µÀç
  • contrast media
    Á¶¿µÁ¦
  • contrast medium
    Á¶¿µÁ¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gadolinium (Gd) based contrast agent
    °¡µ¹¸®´½ Á¶¿µÁ¦
  • 3D phase contrast angiography
    3Â÷¿ø À§»ó ´ëÁ¶ Ç÷°üÁ¶¿µ¼ú
  • CE FAST(contrast enhanced fast acquisition in the st
    ´ëÁ¶µµ Áõ°­ Ç×Á¤»óÅÂÀÇ °í¼Óȹµæ
  • T1 contrast
    T1 ´ëÁ¶µµ
  • T2 contrast
    T2 ´ëÁ¶µµ
  • good contrast
    ¶Ñ·ÇÇÑ ´ëÁ¶µµ
  • hepato renal echo contrast
    °£ ½ÅÀå ¿¡ÄÚ ´ëÁ¶
  • hepato-renal echo contrast
    °£-½ÅÀå (ÊÜ-ãìíô) ¿¡ÄÚ ´ëÁ¶ (ÓßðÎ), °£-½ÅÀå (ÊÜ-ãì
  • phase contrast
    À§»ó ´ëÁ¶
  • phase contrast (PC) MR angiography
    À§»ó ´ëÁ¶ ÀÚ±â°ø¸í Ç÷°üÁ¶¿µ¼ú
  • phase contrast microscopy
    À§»óÂ÷(êÈßÓó¬)Çö¹Ì°æ°Ë»ç
  • phase-contrast microscopy
    À§»óÂ÷Çö¹Ì°æ
  • positive contrast medium
    ¾ç¼º Á¶¿µÁ¦
  • pre contrast enhanced image
    Á¶¿µ Áõ°¡Àü ¿µ»ó
  • proton density contrast
    ¾çÀÚ ¹Ðµµ ´ëÁ¶
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephrotoxicity
    ½Åµ¶¼º
  • nephrotoxicity
    ½Åµ¶¼º.
  • contrast agent
    Á¶¿µÁ¦
  • gadolinium (Gd) based contrast agent
    °¡µ¹¸®´½ Á¶¿µÁ¦
  • barium contrast medium
    ¹Ù·ý Á¶¿µÁ¦
  • binocular contrast
    ¾ç¾È´ëºñ(¡­ÓßÝï).
  • blood oxygenation level dependant contrast
    Ç÷Áß »ê¼ÒÄ¡ ÀÇÁ¸ ´ëÁ¶µµ
  • colo(u)r contrast
    »ö´ëºñ(ßäÓßÝï).
  • color contrast
    »ö´ëºñ
  • contrast
    ´ëÁ¶¹ý(ÓßðÎÛö), ´ëºñ(ÓßÝï).
  • contrast
    ´ëÁ¶ (ÓßðÎ)
  • contrast
    ´ëÁ¶, ´ëºñ, Á¶¿µ
  • contrast bath
    (³Ã¿Â)±³´ë¿å(ÕÒè®ÎßÓÛé±), ¿Â³Ã¿å.
  • contrast bath
    (³Ã¿Â)±³´ë¿å(ÕÒè®ÎßÓÛé±), ¿Â³Ã¿å.
  • contrast colo(u)r
    ´ëºñ»ö(ÓßÝïßä).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antiprotozoal agent
    Ç׿øÃæÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neutron contrast matching technique
    Áß¼ºÀÚ Á¶¿µ´ëÀÀ¼ú(ñéàõí­ðÎç¯Óßëëâú)
  • phase contrast microscope
    À§»óÂ÷(êÈßÓó¬) Çö¹Ì°æ(ßÓÓßðÎúéÚ°Ìð)
  • Agent Orange
    ¿¡ÀÌÁ¨Æ® ¿À·»Áö
  • antibacterial agent
    Ç×±ÕÁ¦(ù÷жð¥)
  • antichaotropic agent
    Ç×(ù÷)ÄÉÀÌ¿À¼º(àõ) Á¦(ð¥)
  • antidotal agent
    ÇØµ¶Á¦Á¦(ú°Ô¸ð²ð¥)
  • antimitotic agent
    Ç×À¯»çºÐ¿­Á¦(ù÷êóÞêÝÂÖ®ð¥)
  • antithyroid agent
    Ç×°©»ó¼±Á¦(ù÷Ë£ßÒàÍð¥)
  • antiviral agent
    Ç×(ù÷) ¹ÙÀÌ·¯½ºÁ¦(ð¥)
  • bactericidal agent
    »ì±ÕÁ¦(߯жð¥)
  • bacteriostatic agent
    Á¤±ÕÁ¦(ð¡Ð¶ð¤)
  • chaotropic agent
    ¹«Áú¼­À¯¹ßÁ¦(Ùíòñßíë¯Û¡ð¥)
  • chelating agent
    ų·¹ÀÌÆ®Á¦(ð¥)
  • chemotherapeutic agent
    È­Çпä¹ýÁ¦(ûùùÊÖûÛöð¥)
  • cytostatic agent
    ¼¼Æ÷Áõ½Ä¾ïÁ¦Á¦(á¬øàñòãÖåäð¤ð¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • contrast agent
    Á¶¿µÁ¦
  • gadolinium based contrast agent
    °¡µ¹¸®´½Á¶¿µÁ¦
  • agent
    ¾à¹°, ÀÛ¿ë¹°Áú, º´ÀÎ
  • alkylating agent
    ¾ËųȭÁ¦, ¾Ëųȭ¾à¹°
  • anabolic agent
    µ¿È­¾à¹°
  • antitumor agent
    Ç׾Ͼà, Á¦¾Ï¾à
  • bleaching agent
    Ç¥¹éÁ¦
  • causative agent
    º´¿øÃ¼, ¿øÀι°Áú
  • chelating agent
    ŰÀÏ·¹ÀÌÆ®¾à
  • chemotherapeutic agent
    È­Çпä¹ýÁ¦
  • diagnostic agent
    Áø´Ü¿ë¾à
  • etiologic agent
    º´ÀÎü
  • immunosuppressive agent
    ¸é¿ª¾ïÁ¦¾à, ¸é¿ª¾ïÁ¦ÀÎÀÚ
  • paramagnetic agent
    »óÀÚ¼ºÁ¦Àç
  • protective agent
    º¸È£¾à, ÇÇÆ÷¾à
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DCS decompression sickness; dense canalicular system; diffuse cortical sclerosis; dorsal column stimulat...
SMCA smooth muscle contracting agent; suckling mouse cataract agent
ACBaE air contrast barium enema
ACBE air contrast barium enema
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
UCA ultrasound contrast agent
CA contrast agent
VEC-DIC Video-enhanced contrast, differential interference contrast
a Agent
CAA Chicken anaemia agent
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nephrotoxicity
    ½Å µ¶¼º
    ½ÅÀå ¼¼Æ÷¿¡ µ¶¼ºÀÌ ÀÖ´Â ¶Ç´Â ÆÄ±«ÇÏ´Â ¼ºÁú.
  • barium contrast medium
    ¹Ù·ý Á¶¿µÁ¦
  • binocular contrast
    ¾ç ¾È ´ëºñ
  • contrast
    ´ëÁ¶µµ, ´ëÁ¶¹ý, ´ëºñ
    ÁÖÀ§ ¶Ç´Â ¾ÈÂÊ¿¡ µé¾îÀÖ´Â ¸Å°³ ¹°Áú, ±×¸®°í ´ëÁ¶ ¸ÅÁú°ú ÁÖÀ§ Á¶Á÷¿¡ ÀÇÇÑ x¼±ÀÇ Èí¼ö¿¡¼­ÀÇ Â÷ÀÌ ¶§¹®¿¡ »ý±ä´Ù. ±¸Á¶ÀÇ ¹æ»ç¼±Àû ½Ã°¢È­ÀÌ´Ù.
  • contrast color
    ´ëºñ»ö
  • contrast enhancement
    Á¶¿µ Áõ°­
  • contrast enhancement scan
    Á¶¿µ Áõ°­ ½ºÄµ
  • contrast material
    Á¶¿µ ¹°Áú, Á¶¿µÁ¦
  • contrast medium
    Á¶¿µÁ¦
    ¾î¶² Á¶Á÷À̳ª °ø°£À» ¹æ»ç¼± ºÒÅõ°ú¼ºÀ¸·Î ¸¸µå´Â ¿µ»ó °Ë»ç¿¡ ¾Õ¼­ ÁÖ»çÇÏ´Â ¹æ»ç¼± ºÒÅõ°ú¼º ¹°Áú.
  • double contrast
    ÀÌÁß Á¶¿µ¼ú
  • double contrast arthrography
    ÀÌÁß °üÀý Á¶¿µ¼ú, ÀÌÁß Á¶¿µ °üÀý Á¶¿µ¼ú
  • hepato renal echo contrast
    °£ ½ÅÀå ¿¡ÄÚ ´ëÁ¶
  • magnetic transfer contrast
    ÀÚÈ­ Àü´Þ ´ëÁ¶µµ
  • phase contrast
    À§»ó ´ëÁ¶
  • pre-contrast enhanced image
    Á¶¿µ Áõ°­Àü ¿µ»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
nephrotoxicity The quality or state of being toxic to kidney cells.
(05 Mar 2000)
contrast agent A substance that is introduced into or around a structure and, because of the difference in absorption of X-rays by the contrast medium and the surrounding tissues, allows radiographic visualisation of the structure.
(18 Nov 1997)
high osmolar contrast agent Ionic water-soluble iodinated contrast media.
Synonym: high osmolar contrast medium.
(05 Mar 2000)
air contrast barium enema A double contrast enema in which air is introduced after coating of the colon with a dense barium suspension for radiographic study.
Synonym: air contrast barium enema.
(05 Mar 2000)
air contrast enema A double contrast enema in which air is introduced after coating of the colon with a dense barium suspension for radiographic study.
Synonym: air contrast barium enema.
(05 Mar 2000)
Allen video enhanced contrast <procedure> A method for enhancing microscopic images pioneered by R D Allen. The digitised image has the background (an out of focus image of the same microscopic field with comparable unevenness of illumination etc.) subtracted and the contrast expanded to utilise the potential contrast range. Interestingly, it is possible to produce images of objects that are below the theoretical limit of resolution microtubules for example.
(18 Nov 1997)
barium contrast material This radiopaque contrast material is either swallowed or given as a enema for the purpose of demonstrating the anatomy of the gastrointestinal tract using X-rays.
(27 Sep 1997)
radiopaque contrast A radiopaque substance (for example metal) will be highlighted (appear white) on a plain X-ray. The use of iodine containing radiopaque contrast dyes allow enhancement of the anatomy demonstrable with conventional X-ray.
(27 Sep 1997)
radiopaque contrast dye A radiopaque substance (for example metal) will be highlighted (appear white) on a plain X-ray. The use of iodine containing radiopaque contrast dyes allow enhancement of the anatomy demonstrable with conventional X-ray.
(27 Sep 1997)
radiopaque contrast material A radiopaque substance (for example metal) will be highlighted (appear white) on a plain X-ray. The use of iodine containing radiopaque contrast dyes allow enhancement of the anatomy demonstrable with conventional X-ray.
(27 Sep 1997)
phase-amplitude contrast <microscopy> The separation and recombination of direct vs. Diffracted rays in a light microscope adjusted to Kohler illumination. at the lower focal plane of the condenser there is an annular diaphragm with an opaque central stop. Through this diaphragm rays are focused as a hollow cone onto the specimen. In the back focal plane of the objective there is a conjugate annular diaphragm (phase plate). If here the undiffracted rays are retarded (by a transparent film of proper thickness on the annulus of the phase plate), bright contrast results. If, instead, the phase-delay film is on the central spot, dark contrast results. With either a bright or a dark-contrast phase plate, the annulus is usually coated with a partially absorbing (very thin) film of silver (Zernike method) or carbon soot (Wilska method) to reduce the higher amplitude (intensity) of the undiffracted rays.
(05 Aug 1998)
phase contrast <microscopy> An optical method devised by F. Zernike for converting the focused image of a phase object (one with differences in refractive index or optical path but not in absorbance), which ordinarily is not visible in focus, into an image with good contrast.
(05 Aug 1998)
phase-contrast microscope <instrument> A specially constructed microscope that has a special condenser and objective containing a phase-shifting ring whereby small differences in index of refraction are made visible as intensity or contrast differences in the image; particularly useful for examining structural details in transparent specimens such as living or unstained cells and tissues.
(05 Mar 2000)
phase contrast microscopy <investigation> A simple nonquantitative form of interference micoscopy of great utility in visualising live cells. Small differences in optical path length due to differences in refractive index and thickness of structures are visualised as differences in light intensity.
(18 Nov 1997)
microscopy, phase-contrast A form of interference microscopy in which variations of the refracting index in the object are converted into variations of intensity in the image. This is achieved by the action of a phase plate.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • contrast
    ´ëÁ¶ÇÏ´Ù
  • contrast
    ´ëÁ¶;´ëºñ(of,between);´ëÁ¶¹ý;ÇöÀúÇÑ Â÷ÀÌ;´ëÁ¶°¡ µÇ´Â °Í;Á¤¹Ý´ëÀÇ ¹°°Ç(»ç¶÷);´ëÁ¶ÇÏ´Ù;´ëºñÇÏ´Ù(compare);..¿Í ÁÁÀº ´ëÁ¶¸¦ ÀÌ·ç´Ù;..¿Í ´ëÁ¶ÇÏ¿©(´«¿¡) ¶Ñ·ÇÀÌ º¸ÀÌ°Ô ÇÏ´Ù;..¿Í ´ëÁ¶¸¦ ÀÌ·ç´Ù;´ëºñÇÏ¿© Â÷À̸¦ ¶Ñ·ÇÀÌ ³ªÅ¸³»´Ù;~able
  • phase contrast
    À§»óÂ÷
  • agent
    ´ë¸®ÀÎ
  • Eaton agent
    (ÀÇ)ÀÌÆ° ÀÎÀÚ
  • Indian agent
    (¹Ì ij³ª´Ù)Àεð¾ð °ü¸®°ü
  • ad agent
    ±¤°í ´ëÇà¾÷ÀÚ
  • agent
    ´ë¸®ÀÎ;ÁÖ¼±ÀÎ;ÇàÀ§ÀÚ;ÀÛÀÎ
  • book agent
    ¼­Àû¿ÜÆÇ¿ø
  • business agent
    ¾÷¹«´ë¸®
  • commission agent
    °Å°£²Û;Á߸ÅÀÎ;»ç¼³ ¸¶±ÇÀå¼ö
  • consular agent
    ¿µ»ç ´ë¸®
  • contact agent
    Ã˸Å;Á¢ÃËÁ¦(catalyzer)
  • conversion agent
    Àüȯ ´ë¸® ±â°ü
  • county agent
    (¿¬¹æ.ÁÖÁ¤ºÎ°¡ ÆÄ°ßÇÑ)³ó»ç °í¹®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á